Dynamics of decision-making in MS: Are we taking the long view?

This activity is an independently supported presentation by Novartis Pharma AG and is not included in the MSVirtual2020 accredited program. No CME credit is provided.

CHAIR:
Kate Milliken, MS Patient Advocate

FACULTY:
Daniel Becker, John Hopkins
Michael Platt, University of Pennsylvania
Karen Vernon, Salford Royal NHS Foundation Trust

Exploring the role of real-world data in multiple sclerosis

This activity is an independently supported presentation by EMD Serono and is not included in the MSVirtual2020 accredited program. No CME credit is provided.

CO-CHAIRS:
Ravi Dukkipati, Wellspan Neurosciences
Gavin Giovannoni, Queen Mary University of London

FACULTY:
Wallace Brownlee, National Hospital for Neurology and Neurosurgery
Kerstin Hellwig, Ruhr University
Suzanne Hodgkinson, University of New South Wales Medicine

A new treatment option for patients with relapsing forms of MS

This activity is an independently supported presentation by Bristol Myers Squibb and is not included in the MSVirtual2020 accredited program. No CME credit is provided.

CHAIR:
Bruce Cree, University of California, San Francisco

FACULTY:
Giancarlo Comi, Vita-Salute San Raffaele University
Adil Javed, University of Chicago

Topics:
COVID-19 & MS - Supported by Bristol Myers Squibb
NMOSD - Supported by Genentech, A Member of the Roche Group
Women & underrepresented diverse populations in MS - Supported by Novartis Pharma AG